Listed here are some latest items written
April 15, 2024 | I. Glenn Cohen, Harvard Regulation College
The convergence of present psychedelic regulatory pathways could convey each advantages and new challenges.
April 16, 2024 | Molly Candon, College of Pennsylvania
Insurance coverage reimbursement for psychedelic remedy is integral to affordability of therapy.
April 17, 2024 | Joshua Siegel, Washington College College of Drugs in St. Louis
Coverage makers should account for the comparatively low dangers of psychedelic use when deciding find out how to regulate it.
April 18, 2024 | Victoria Litman, Roger Williams College College of Regulation
Dispensaries might fill the regulatory void for psychedelics and promote public well being.
April 22, 2024 | Joanna Neill, College of Manchester
Lawmakers ought to decrease the regulatory hurdles that stop analysis into psilocybin-assisted psychotherapy.
A brand new period of psychedelic medication in Australia
April 23, 2024 | Daniel Perkins, College of Melbourne
Australia is implementing a brand new framework to manage the medicinal use of psychedelic substances similar to MDMA and psilocybin.
Learn all at
International Views on Psychedelic Regulation